Integrated BioPharma (INBP) Short Interest Ratio & Short Volume → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free INBP Stock Alerts $0.22 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Integrated BioPharma Short Interest DataCurrent Short Volume1,000 sharesPrevious Short Volume3,400 sharesChange Vs. Previous Month-70.59%Dollar Volume Sold Short$270.00Short Interest Ratio / Days to Cover0.1Last Record DateNovember 15, 2023Outstanding Shares30,100,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume1,000 sharesAverage Trading Volume7,868 sharesToday's Volume Vs. Average13% Short Selling Integrated BioPharma ? Sign up to receive the latest short interest report for Integrated BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINBP Short Interest Over TimeINBP Days to Cover Over TimeINBP Percentage of Float Shorted Over Time Ad Behind the Markets[BUY ALERT] Our #1 A.I. Stock for MarchIt's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> Integrated BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20231,000 shares $270.00 -70.6%N/A0.1 $0.27 10/31/20233,400 shares $822.12 -15.0%N/A0.1 $0.24 10/15/20234,000 shares $1,060.00 +700.0%N/A0.7 $0.27 9/30/2023500 shares $140.00 -70.6%N/A0 $0.28 9/15/20231,700 shares $484.50 No ChangeN/A1.7 $0.29 8/31/20231,700 shares $477.70 No ChangeN/A1.7 $0.28 Get the Latest News and Ratings for INBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. 8/15/20231,700 shares $510.15 +240.0%N/A8.5 $0.30 7/31/2023500 shares $165.20 No ChangeN/A0 $0.33 7/15/2023500 shares $167.40 No ChangeN/A0 $0.33 6/30/2023500 shares $165.61 No ChangeN/A0.3 $0.33 6/15/2023500 shares $165.00 -37.5%N/A0.4 $0.33 5/31/2023800 shares $272.00 +60.0%N/A0.3 $0.34 5/15/2023500 shares $190.00 No ChangeN/A0.1 $0.38 4/30/2023500 shares $190.00 No ChangeN/A0.2 $0.38 4/15/2023500 shares $189.88 -80.8%N/A0.1 $0.38 3/31/20232,600 shares $995.80 -42.2%N/A0.7 $0.38 3/15/20234,500 shares $1,755.00 -25.0%N/A2.5 $0.39 2/28/20236,000 shares $2,640.00 +62.2%N/A1.4 $0.44 2/15/20233,700 shares $1,457.80 +2.8%N/A0.3 $0.39 1/31/20233,600 shares $1,260.00 +2.9%N/A1.2 $0.35 1/15/20233,500 shares $1,540.00 No ChangeN/A11.7 $0.44 12/30/20223,500 shares $1,461.25 No ChangeN/A5.8 $0.42 12/15/20223,500 shares $1,348.20 +133.3%N/A0.8 $0.39 11/30/20221,500 shares $574.50 +650.0%N/A0.3 $0.38 11/15/2022200 shares $86.00 No ChangeN/A0.1 $0.43 9/15/20221,300 shares $662.35 No ChangeN/A0.1 $0.51 6/15/20221,800 shares $1,083.60 +125.0%N/A0.2 $0.60 5/31/2022800 shares $647.60 -55.6%N/A0.1 $0.81 5/15/20221,800 shares $1,439.10 -88.5%N/A0.1 $0.80 4/30/202215,600 shares $12,324.00 +766.7%N/A0.7 $0.79 4/15/20221,800 shares $1,440.00 +1,700.0%N/A0.1 $0.80 3/31/2022100 shares $78.95 -97.2%N/A0 $0.79 3/15/20223,600 shares $3,024.00 +28.6%N/A0.3 $0.84 2/28/20222,800 shares $2,658.60 -42.9%N/A0.2 $0.95 2/15/20224,900 shares $4,753.00 No ChangeN/A0.1 $0.97 1/15/20223,300 shares $3,531.00 +22.2%N/A0.2 $1.07 12/31/20212,700 shares $2,808.00 +17.4%N/A0.1 $1.04 12/15/20212,300 shares $2,252.85 -54.0%N/A0.1 $0.98 11/30/20215,000 shares $4,947.50 +4,900.0%N/A0.1 $0.99 11/15/2021100 shares $92.50 -95.2%N/A0 $0.93[BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it.Get the name of the stock here - before it takes off >>> INBP Short Interest - Frequently Asked Questions What is Integrated BioPharma's current short interest? Short interest is the volume of Integrated BioPharma shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 1,000 shares of INBP short. Learn More on Integrated BioPharma's current short interest. Is Integrated BioPharma's short interest increasing or decreasing? Integrated BioPharma saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,000 shares, a decline of 70.6% from the previous total of 3,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Integrated BioPharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Integrated BioPharma: Clever Leaves Holdings Inc. (0.93%), Azitra, Inc. (1.51%), Soligenix, Inc. (0.65%), Xenetic Biosciences Inc (0.18%), Protagenic Therapeutics, Inc. (0.34%), Biofrontera Inc. (6.06%), Sonnet BioTherapeutics Holdings, Inc. (20.05%), Enveric Biosciences, Inc. (3.23%), Alterity Therapeutics Limited (0.32%), ZyVersa Therapeutics, Inc. (16.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Integrated BioPharma stock? Short selling INBP is an investing strategy that aims to generate trading profit from Integrated BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Integrated BioPharma? A short squeeze for Integrated BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBP, which in turn drives the price of the stock up even further. How often is Integrated BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBP, twice per month. The most recent reporting period available is November, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Clever Leaves Short Squeeze Azitra Short Squeeze Soligenix Short Squeeze Xenetic Biosciences Short Squeeze Protagenic Therapeutics Short Squeeze Biofrontera Short Squeeze Sonnet BioTherapeutics Short Squeeze Enveric Biosciences Short Squeeze Alterity Therapeutics Short Squeeze ZyVersa Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INBP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings